NuVasive names 2 new board members — 5 key notes

Spinal Tech

NuVasive named two new members to their board of directors.

Robert F. Friel and Donald J. Rosenberg were named independent directors of the company. The new appointments are effective Feb. 12, 2016. Here are five things to know about the new appointments:

 

1. Mr. Friel will be a member of the board's compensation committee; Mr. Rosenberg will be a member of the board's compensation committee and the nominating and corporate governance committee.

 

2. The NuVasive's board is now nine directors, eight of which are independent directors.

 

3. Mr. Friel is the chairman, CEO and President of PerkinElmer and has more than 35 years of finance and operational experience. Mr. Rosenberg is executive vice president, general counsel and corporate security of Qualcomm.

 

4. Throughout his career, Mr. Friel has experience held several senior management positions with AlliedSignal — now Honeywell.

 

5. Mr. Rosenberg has experience in corporate governance, compliance, law department management, litigation, securities regulation, intellectual property and competition issues.

 

"As we continue to grow and mature as a company, their collective years of broad experience across important industries will add a valuable perspective to our company," said NuVasive Chairman and CEO Gregory T. Lucier. "We appreciate their willingness to serve as directors and look forward to benefiting from their judgment and counsel."

 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Podcast

Featured Whitepapers